Healthcare

Global Bioanalytical Testing Services, 2021–2027

Acquisition of Disruptive Technologies will be the Key to Driving Growth

INDUSTRY
Healthcare

RELEASE DATE
23-Aug-2022
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
PD4D-01-00-00-00
SKU
HC03578-NA-MT_26838
Yes
SHARE

Global Bioanalytical Testing Services, 2021–2027
Published on: 23-Aug-2022 | SKU: HC03578-NA-MT_26838

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

As the pharma market recovers from the debilitating impact of COVID-19 on the drug discovery and development pipelines, there is an increasing requirement for outsourcing services in the form of contract research organizations (CROs) and contract development & manufacturing organizations (CDMOs), which is likely to drive the already strong drug development activities. Bioanalytical testing is one of the core aspects of drug development. The testing modules include biomarker testing, immunogenicity testing, toxicology, pharmacokinetics (PK), and pharmacodynamics (PD). These modules essentially cover the entire value chain of drug development. Service providers adopt integrated systems and technologies, such as robotic automation, laboratory information management systems (LIMS), advanced mass spectrometry, and bioassays, to facilitate sensitivity and accuracy in the analysis of samples. With the advent of innovative biologics and biosimilars, including novel mRNA therapies, there is a constant requirement for bioanalytical testing services, which continues to provide opportunities to service providers such as full-service CROs, central laboratory vendors, and laboratory research CROs and CDMOs across the globe. In light of growing innovation, there is a strong reliance on fit-for-purpose drug testing and quality-by-design methodologies, which ensure a step-by-step drug development approach, thus increasing success rates and providing pharma/biotech sponsors with a crucial competitive advantage.

This report on global bioanalytical testing services identifies some of the leading growth opportunity areas in terms of customized bioassay and biomarker testing services, highlighting the growing trend of CRO subcontracting to specifically cater to the specialized drug development and accuracy needs. In addition, the market is witnessing a simultaneous adoption of artificial intelligence (AI) and cloud-based LIMS solutions, which work hand in hand with the drug development activities for petabyte-scale data management (genomics/proteomics data sets).

Key Issues Addressed

  • How is the bioanalytical testing services market expected to grow through the forecast period?
  • What are key trends driving and restricting the outsourcing of bioanalytical testing services?
  • What are the regional trends shaping bioanalytical testing services? Which are the high-growth regions?
  • What are the key strategies that global stakeholders are adopting to better serve customers while ensuring growth?
  • What are the notable investment trends that are helping market players align themselves to industry needs?
  • What are the key growth opportunities for CROs, sponsors, and technology participants in the ecosystem?

Author: Aarti Siddhesh Chitale

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on Bioanalytical Testing Services

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Market Overview and Segmentation

Key Market Definitions and Segmentation by Type of Testing Services

Bioanalytical Testing Services across Drug Value Chain

Key Trends Analysis by Service Type and Methodology

Growth Drivers

Growth Restraints

Rising Trend of Outsourcing of Bioanalytical Testing

Evolving Vendor Landscape

Evolving Vendor Landscape (continued)

Investment Trends

Increasing Capacity through Facility Expansions

Increasing Capacity Through Facility Expansions (continued)

Increasing Capacity Through Facility Expansions (continued)

Building Bioanalytical Expertise through Acquisitions

Building Bioanalytical Expertise through Acquisitions (continued)

Building Bioanalytical Expertise through Acquisitions (continued)

Partnerships for Technology Access

Key Growth Metrics

Forecast Assumptions

Revenue Forecast—Global

Revenue Forecast Analysis

Revenue Forecast Analysis (continued)

Revenue Share by Type of Testing Services

Revenue Share Analysis by Type of Testing Services

Revenue Share Analysis by Type of Testing Services (continued)

Revenue Share by Large Molecule versus Small Molecules

Revenue Share Analysis by Large Molecule vs. Small Molecules

Revenue Share Analysis by Large Molecule vs. Small Molecules (continued)

Revenue Share by Region

Revenue Share Analysis by Region

Competitive Environment

Key Competitors by Region

Revenue Share

Revenue Share Analysis

Revenue Share Analysis (continued)

Growth Opportunity 1—Bioanalytical Characterization of mRNA Therapeutics

Growth Opportunity 1—Bioanalytical Characterization of mRNA Therapeutics (continued)

Growth Opportunity 2—Customized Biomarker Assay Development for CGT Testing

Growth Opportunity 2—Customized Biomarker Assay Development for CGT Testing (continued)

Growth Opportunity 3—Sub-contracting to Specialty CROs for Oncology Pipeline

Growth Opportunity 3—Sub-contracting to Specialty CROs for Oncology Pipeline (continued)

Growth Opportunity 4—Cloud-enabled LIMS for DMPK Profiling

Growth Opportunity 4—Cloud-enabled LIMS for DMPK Profiling (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

Legal Disclaimer

List of Figures
  • Bioanalytical Testing Services: Growth Drivers, Global, 2022 2027
  • Bioanalytical Testing Services: Growth Restraints, Global, 2022 2027
  • Global Bioanalytical Testing Services: Global, 2021
  • Global Bioanalytical Testing Services: Revenue Forecast, Global, 2018 2027
  • Global Bioanalytical Testing Services: Revenue Share by Type of Testing Services, Global, 2021
  • Global Bioanalytical Testing Services: Revenue Share by Large Molecule vs. Small Molecule, Global, 2021
  • Global Bioanalytical Testing Services: Revenue Share by Region, Global, 2021
  • Global Bioanalytical Testing Services: Revenue Share of Top Participants, Global, 2021

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

16 Nov 2026   |   North America   |   Frost Radar

Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026

This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...

03 Nov 2026   |   North America   |   Market Research

Enterprise Imaging Market, United States, 2025–2030

Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...

02 Nov 2026   |   Global   |   Market Research

Continuous Glucose Monitoring Market, Global, 2026

The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...

28 Oct 2026   |   Global   |   Frost Radar

Frost Radar™: Health Monitoring Wearable Solutions, 2026

The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...

26 Oct 2026   |   Global   |   Technology Research

Game-Changing Innovations Transforming Cardiovascular Care

The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interve...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.